Encompass Health (EHC) Stock Forecast, Price Target & Predictions
EHC Stock Forecast
Encompass Health stock forecast is as follows: an average price target of $97.00 (represents a -1.95% downside from EHC’s last price of $98.93) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.
EHC Price Target
The average price target for Encompass Health (EHC) is $97.00 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $110.00 to $83.00. This represents a potential -1.95% downside from EHC's last price of $98.93.
EHC Analyst Ratings
According to 6 Wall Street analysts, Encompass Health's rating consensus is 'Buy'. The analyst rating breakdown for EHC stock is 1 'Strong Buy' (16.67%), 5 'Buy' (83.33%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Encompass Health Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 26, 2024 | Ben Hendrix | RBC Capital | $105.00 | $96.75 | 8.53% | 6.14% |
| Sep 25, 2024 | AJ Rice | UBS | $110.00 | $95.26 | 15.47% | 11.19% |
| May 22, 2024 | Frank Morgan | RBC Capital | $95.00 | $85.86 | 10.65% | -3.97% |
| Apr 25, 2024 | Ann Hynes | Mizuho Securities | $95.00 | $82.80 | 14.73% | -3.97% |
| Mar 28, 2024 | Andrew Mok | Barclays | $101.00 | $81.79 | 23.49% | 2.09% |
| May 03, 2022 | - | RBC Capital | $85.00 | $68.24 | 24.56% | -14.08% |
| May 02, 2022 | - | Raymond James | $85.00 | $68.83 | 23.49% | -14.08% |
| Apr 29, 2022 | - | Credit Suisse | $83.00 | $68.46 | 21.24% | -16.10% |
| Apr 29, 2021 | Scott Fidel | Stephens | $100.00 | $84.62 | 18.18% | 1.08% |
The latest Encompass Health stock forecast, released on Sep 26, 2024 by Ben Hendrix from RBC Capital, set a price target of $105.00, which represents a 8.53% increase from the stock price at the time of the forecast ($96.75), and a 6.14% increase from EHC last price ($98.93).
Encompass Health Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 5 |
| Avg Price Target | - | $107.50 | $101.20 |
| Last Closing Price | $98.93 | $98.93 | $98.93 |
| Upside/Downside | -100.00% | 8.66% | 2.29% |
In the current month, the average price target of Encompass Health stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Encompass Health's last price of $98.93. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 29, 2024 | UBS | Buy | Buy | Hold |
| Oct 29, 2024 | KeyBanc | Overweight | Overweight | Hold |
| Oct 29, 2024 | Barclays | Overweight | Overweight | Hold |
| Oct 11, 2024 | Truist Financial | Underperform | Underperform | Hold |
| Oct 10, 2024 | KeyBanc | - | Overweight | Initialise |
| Sep 26, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Sep 25, 2024 | UBS | Buy | Buy | Hold |
| Aug 06, 2024 | RBC Capital | Underperform | Underperform | Hold |
| Aug 06, 2024 | Stephens | Buy | Buy | Hold |
| Jul 10, 2024 | Stephens | Strong Buy | Strong Buy | Hold |
Encompass Health's last stock rating was published by UBS on Oct 29, 2024. The company gave EHC a "Buy" rating, the same as its previous rate.
Encompass Health Financial Forecast
Encompass Health Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.21B | $1.19B | $1.16B | $1.14B | $1.09B | $1.33B | $1.33B | $1.32B | $1.28B | $1.29B | $1.23B | $1.21B | $1.17B | $1.07B | $1.18B | $1.18B | $1.16B |
| Avg Forecast | $1.63B | $1.58B | $1.53B | $1.56B | $1.50B | $1.47B | $1.42B | $1.43B | $1.38B | $1.33B | $1.30B | $1.27B | $1.24B | $1.20B | $1.16B | $1.14B | $1.12B | $1.06B | $1.34B | $1.33B | $1.31B | $1.31B | $1.27B | $1.23B | $1.21B | $1.18B | $1.05B | $1.20B | $1.18B | $1.15B |
| High Forecast | $1.64B | $1.59B | $1.55B | $1.57B | $1.51B | $1.48B | $1.43B | $1.44B | $1.40B | $1.33B | $1.30B | $1.27B | $1.25B | $1.21B | $1.17B | $1.15B | $1.13B | $1.06B | $1.34B | $1.33B | $1.31B | $1.31B | $1.27B | $1.23B | $1.21B | $1.18B | $1.05B | $1.20B | $1.18B | $1.15B |
| Low Forecast | $1.61B | $1.56B | $1.52B | $1.54B | $1.49B | $1.45B | $1.40B | $1.42B | $1.36B | $1.33B | $1.30B | $1.27B | $1.23B | $1.19B | $1.15B | $1.13B | $1.11B | $1.06B | $1.34B | $1.33B | $1.31B | $1.31B | $1.27B | $1.23B | $1.21B | $1.18B | $1.05B | $1.20B | $1.18B | $1.15B |
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 10 | 9 | 3 | 3 | 6 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 9 | 9 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.02% | 1.01% | 1.01% | 1.02% | 0.99% | 1.01% | 1.01% | 0.98% | 1.01% | 1.00% | 1.01% | 0.99% | 1.02% | 0.99% | 1.01% | 1.01% |
Encompass Health's average Quarter revenue forecast for Dec 23 based on 6 analysts is $1.24B, with a low forecast of $1.23B, and a high forecast of $1.25B. EHC's average Quarter revenue forecast represents a 2.50% increase compared to the company's last Quarter revenue of $1.21B (Sep 23).
Encompass Health EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 10 | 9 | 3 | 3 | 6 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 9 | 9 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $248.20M | $260.10M | $246.50M | $251.70M | $207.60M | $225.60M | $247.40M | $229.00M | $238.90M | $258.00M | $247.10M | $232.50M | $214.80M | $151.80M | $216.10M | $197.80M | $227.30M |
| Avg Forecast | $310.67M | $301.10M | $292.73M | $297.37M | $286.66M | $280.06M | $270.56M | $274.14M | $263.46M | $253.80M | $248.70M | $256.88M | $236.39M | $228.53M | $222.06M | $233.53M | $271.09M | $217.48M | $274.26M | $212.30M | $266.82M | $268.38M | $259.48M | $177.79M | $246.20M | $241.49M | $215.00M | $211.02M | $240.64M | $235.20M |
| High Forecast | $313.65M | $303.99M | $295.53M | $300.22M | $289.40M | $282.74M | $273.15M | $276.06M | $267.28M | $253.86M | $248.70M | $308.26M | $238.65M | $230.87M | $224.19M | $280.23M | $325.31M | $217.48M | $274.26M | $254.76M | $266.82M | $268.38M | $259.48M | $213.35M | $246.20M | $241.49M | $215.00M | $253.22M | $240.64M | $235.20M |
| Low Forecast | $307.68M | $298.20M | $289.91M | $294.50M | $283.90M | $277.36M | $267.96M | $271.50M | $259.65M | $253.74M | $248.70M | $205.51M | $234.48M | $226.90M | $219.93M | $186.82M | $216.87M | $217.48M | $274.26M | $169.84M | $266.82M | $268.38M | $259.48M | $142.23M | $246.20M | $241.49M | $215.00M | $168.81M | $240.64M | $235.20M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.09% | 1.17% | 1.06% | 0.93% | 0.95% | 0.82% | 1.17% | 0.86% | 0.89% | 0.99% | 1.39% | 0.94% | 0.89% | 0.71% | 1.02% | 0.82% | 0.97% |
6 analysts predict EHC's average Quarter EBITDA for Dec 23 to be $236.39M, with a high of $238.65M and a low of $234.48M. This is -4.76% lower than Encompass Health's previous annual EBITDA (Sep 23) of $248.20M.
Encompass Health Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 10 | 9 | 3 | 3 | 6 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 9 | 9 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $85.30M | $91.40M | $87.70M | $89.40M | $85.50M | $71.30M | $87.50M | $115.70M | $100.00M | $113.30M | $107.30M | $86.00M | $77.70M | $33.50M | $87.00M | $67.60M | $97.60M |
| Avg Forecast | $136.64M | $131.06M | $128.72M | $130.88M | $120.38M | $120.16M | $122.20M | $121.91M | $104.95M | $96.19M | $103.31M | $100.12M | $83.32M | $80.06M | $75.78M | $91.02M | $108.44M | $65.06M | $98.47M | $82.74M | $107.06M | $108.13M | $99.73M | $77.20M | $87.10M | $75.73M | $33.41M | $84.95M | $85.55M | $90.93M |
| High Forecast | $138.34M | $132.69M | $130.32M | $132.51M | $121.88M | $121.65M | $123.72M | $126.98M | $111.13M | $96.24M | $103.32M | $120.15M | $87.34M | $87.34M | $76.72M | $109.22M | $130.12M | $65.06M | $98.47M | $99.29M | $107.06M | $108.13M | $101.44M | $92.64M | $87.10M | $75.73M | $33.41M | $101.94M | $85.55M | $90.93M |
| Low Forecast | $134.93M | $129.42M | $127.11M | $129.24M | $118.88M | $118.65M | $120.67M | $115.81M | $100.84M | $96.15M | $103.31M | $80.10M | $80.31M | $74.86M | $74.83M | $72.82M | $86.75M | $65.06M | $98.47M | $66.20M | $107.06M | $108.13M | $98.02M | $61.76M | $87.10M | $75.73M | $33.41M | $67.96M | $85.55M | $90.93M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.07% | 1.21% | 0.96% | 0.82% | 1.31% | 0.72% | 1.06% | 1.08% | 0.92% | 1.14% | 1.39% | 0.99% | 1.03% | 1.00% | 1.02% | 0.79% | 1.07% |
Encompass Health's average Quarter net income forecast for Dec 23 is $83.32M, with a range of $80.31M to $87.34M. EHC's average Quarter net income forecast represents a -2.32% decrease compared to the company's last Quarter net income of $85.30M (Sep 23).
Encompass Health SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 10 | 9 | 3 | 3 | 6 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 9 | 9 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $722.60M | $705.90M | $686.20M | $670.30M | $655.90M | $853.40M | $845.30M | $841.60M | $793.80M | $782.60M | $746.00M | $744.30M | $724.30M | $715.20M | $734.90M | $753.10M | $735.10M |
| Avg Forecast | $818.41M | $793.20M | $771.14M | $783.36M | $755.15M | $737.76M | $712.75M | $722.18M | $694.04M | $668.58M | $655.14M | $967.23M | $622.72M | $602.03M | $584.99M | $879.30M | $996.29M | $535.90M | $675.80M | $799.36M | $657.48M | $661.31M | $639.38M | $536.76M | $606.66M | $595.07M | $529.78M | $717.61M | $592.96M | $579.55M |
| High Forecast | $826.25M | $800.79M | $778.53M | $790.86M | $762.38M | $744.83M | $719.57M | $727.23M | $704.10M | $668.74M | $655.14M | $1.16B | $628.68M | $608.18M | $590.59M | $1.06B | $1.20B | $535.90M | $675.80M | $959.23M | $657.48M | $661.31M | $639.38M | $644.11M | $606.66M | $595.07M | $529.78M | $861.13M | $592.96M | $579.55M |
| Low Forecast | $810.53M | $785.56M | $763.71M | $775.82M | $747.87M | $730.66M | $705.88M | $715.22M | $683.99M | $668.43M | $655.14M | $773.78M | $617.70M | $597.72M | $579.35M | $703.44M | $797.04M | $535.90M | $675.80M | $639.49M | $657.48M | $661.31M | $639.38M | $429.40M | $606.66M | $595.07M | $529.78M | $574.09M | $592.96M | $579.55M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.20% | 1.21% | 0.78% | 0.67% | 1.22% | 1.26% | 1.06% | 1.28% | 1.20% | 1.22% | 1.39% | 1.23% | 1.22% | 1.35% | 1.02% | 1.27% | 1.27% |
Encompass Health's average Quarter SG&A projection for Dec 23 is $622.72M, based on 6 Wall Street analysts, with a range of $617.70M to $628.68M. The forecast indicates a -13.82% fall compared to EHC last annual SG&A of $722.60M (Sep 23).
Encompass Health EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 10 | 9 | 3 | 3 | 6 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 9 | 9 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.85 | $0.91 | $0.88 | $0.89 | $0.86 | $0.72 | $0.88 | $1.17 | $1.01 | $1.14 | $1.08 | $0.87 | $0.78 | $0.34 | $0.88 | $0.69 | $0.99 |
| Avg Forecast | $1.34 | $1.28 | $1.26 | $1.28 | $1.18 | $1.18 | $1.20 | $1.19 | $1.03 | $0.94 | $1.01 | $0.94 | $0.82 | $0.78 | $0.74 | $0.70 | $0.83 | $0.64 | $0.97 | $0.91 | $1.05 | $1.06 | $0.98 | $0.82 | $0.85 | $0.74 | $0.33 | $0.84 | $0.84 | $0.89 |
| High Forecast | $1.35 | $1.30 | $1.28 | $1.30 | $1.19 | $1.19 | $1.21 | $1.24 | $1.09 | $0.94 | $1.01 | $0.94 | $0.86 | $0.86 | $0.75 | $0.71 | $0.84 | $0.64 | $0.97 | $0.91 | $1.05 | $1.06 | $0.99 | $0.82 | $0.85 | $0.74 | $0.33 | $0.84 | $0.84 | $0.89 |
| Low Forecast | $1.32 | $1.27 | $1.24 | $1.27 | $1.16 | $1.16 | $1.18 | $1.13 | $0.99 | $0.94 | $1.01 | $0.94 | $0.79 | $0.73 | $0.73 | $0.70 | $0.82 | $0.64 | $0.97 | $0.91 | $1.05 | $1.06 | $0.96 | $0.82 | $0.85 | $0.74 | $0.33 | $0.84 | $0.84 | $0.89 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | 1.23% | 1.25% | 1.07% | 1.35% | 0.75% | 0.96% | 1.11% | 0.95% | 1.17% | 1.31% | 1.02% | 1.05% | 1.04% | 1.04% | 0.82% | 1.11% |
According to 6 Wall Street analysts, Encompass Health's projected average Quarter EPS for Dec 23 is $0.82, with a low estimate of $0.79 and a high estimate of $0.86. This represents a -3.99% decrease compared to EHC previous annual EPS of $0.85 (Sep 23).
Encompass Health Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ACHC | Acadia Healthcare Company | $39.10 | $82.33 | 110.56% | Buy |
| MODV | ModivCare | $16.31 | $24.50 | 50.21% | Buy |
| INNV | InnovAge | $4.70 | $6.80 | 44.68% | Hold |
| EHAB | Enhabit | $7.46 | $10.25 | 37.40% | Hold |
| PNTG | Pennant Group | $30.78 | $34.67 | 12.64% | Buy |
| ADUS | Addus HomeCare | $120.99 | $132.80 | 9.76% | Buy |
| SEM | Select Medical | $38.09 | $40.00 | 5.01% | Buy |
| ENSG | Ensign Group | $144.66 | $148.20 | 2.45% | Buy |
| EHC | Encompass Health | $98.93 | $97.00 | -1.95% | Buy |